Ironwood Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Ironwood Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $6.10. The average 1-year stock price forecast is 59.69% higher than the current stock price, while the lowest is $3.70 (-3.14%) and the highest is $10 (+161.78%).

Price Target: $6.10 (+59.69%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$3.70	$6.10	$5.35	$10
Change	-3.14%	+59.69%	+40.05%	+161.78%

* Price targets were last updated on May 6, 2026.

Analyst Ratings

The average analyst rating for Ironwood Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Jan '26	Feb '26	May '26
Strong Buy	0	0	0	1	1	1
Buy	0	0	0	1	1	1
Hold	5	5	4	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Chase Knickerbocker Craig-Hallum	Craig-Hallum	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 14, 2026
Mohit Bansal Wells Fargo	Wells Fargo	Hold Maintains $5	Hold	Maintains	$5	+30.89%	May 6, 2026
Jason Butler Citizens JMP	Citizens JMP	Buy Maintains $8 → $10	Buy	Maintains	$8 → $10	+161.78%	Feb 26, 2026

Financial Forecast

Revenue This Year

459.48M

from 296.15M

55.15%

from 296.15M

Revenue Next Year

478.35M

from 459.48M

4.11%

from 459.48M

EPS This Year

1.09

from 0.25

336.00%

from 0.25

EPS Next Year

1.44

from 1.09

32.11%

from 1.09

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	413.75M	410.60M	442.74M	351.41M	296.15M	459.48M
Revenue Growth	6.22%	-0.76%	7.83%	-20.63%	-15.73%	55.15%
Gross Profit	343.35M	366.33M	337.95M	239.99M	201.02M	441.10M
Gross Margin	82.98%	89.22%	76.33%	68.29%	67.88%	96.00%
Operating Income	232.22M	250.34M	195.84M	96.36M	118.95M	297.25M
Net Income	528.45M	175.07M	-1.00B	880.00K	24.02M	188.23M
EPS	-	-	-	-	0.25	1.09
EPS Growth	-	-	-	-	525.00%	336.00%
Forward PE	8.43	11.24	14.14	13.42	7.84	3.50
Free Cash Flow	170.05M	161.46M	204.13M	80.71M	111.69M	238.00M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	463.5M
Avg	459.5M
Low	452.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	56.5%
Avg	55.1%
Low	52.6%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	1.09
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	336.0%
Low	-